{"symbol":"BSX","fiscalQuarter":"Q2-2021","reportDate":"2021-07-27","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q2-2021","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 3.5%","keyNumbers":[{"metric":"EPS","actual":"$0.40","expected":"N/A","surprise":"+7.24%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS performance despite not providing revenue figures.","They highlighted ongoing efforts to enhance product offerings and market presence."],"summary":"Overall, management conveyed a sense of cautious optimism about the company's performance. They emphasized their commitment to innovation and growth."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 3.5% increase. Investors may view the EPS beat as a sign of the company's resilience and potential for future growth. However, the lack of revenue data and guidance leaves some uncertainty about overall performance.","metaDescription":"Boston Scientific (BSX) Q2 2021 earnings: EPS beat by 7.24%. Stock up 3.5%. Full breakdown."}}